Cardiometabolic Syndrome Ups Subclinical Atherosclerosis Risk

Share this content:
Cardiometabolic Syndrome Ups Subclinical Atherosclerosis Risk
Cardiometabolic Syndrome Ups Subclinical Atherosclerosis Risk

FRIDAY, Oct. 28, 2016 (HealthDay News) -- Cardiometabolic syndrome (CMS) is associated with increased risk of subclinical atherosclerosis, but the risk is attenuated by high fitness, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Sae Young Jae, Ph.D., from the University of Seoul in South Korea, and colleagues examined whether CMS correlates with subclinical atherosclerosis in a study population of 2,107 men participating in a health screening program that included coronary artery calcification (CAC) and carotid artery intima-media thickness (CIMT) measures. Subclinical atherosclerosis was defined as CAC score >0 and a mean CIMT >75th percentile.

The researchers found that participants with CMS had higher odds ratios of having a positive CAC and CIMT (odds ratios, 1.41 and 1.70, respectively) compared to those without CMS, after adjustment for confounding variables. Compared with lower fitness, upper levels of fitness correlated with lower prevalence of CAC and CIMT (odds ratios, 0.69 and 0.53, respectively). Compared to fit participants without CMS, unfit participants with CMS were 1.47 and 2.35 times more likely to exhibit CAC and CIMT, respectively. Odds ratios for the prevalence of CAC and CIMT were similar for fit participants with and without CMS.

"Our findings demonstrate that CMS is associated with an increased risk of subclinical atherosclerosis but that high fitness appears to attenuate these associations in men," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »